SpringWorks Therapeutics (SWTX) News Today $46.31 +0.04 (+0.09%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SWTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Rafferty Asset Management LLC Has $4.44 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Rafferty Asset Management LLC lessened its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 11.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 122,943 shares of the company's stock after seMay 21 at 5:28 AM | marketbeat.com30,811 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Tema Etfs LLCTema Etfs LLC acquired a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 30,811 shares of the company's stock, valued aMay 20 at 6:16 AM | marketbeat.comEnsign Peak Advisors Inc Lowers Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Ensign Peak Advisors Inc trimmed its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 88.5% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 19,041 shares of the company's stock after selling 145,903 shares during the period. EnsigMay 19 at 4:15 AM | marketbeat.comSphera Funds Management LTD. Makes New $3.61 Million Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Sphera Funds Management LTD. purchased a new position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 100,000 shares of the compMay 18 at 6:55 AM | marketbeat.comPatient Square Capital LP Invests $3.37 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Patient Square Capital LP purchased a new stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 93,137 shares of the companMay 16, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by D. E. Shaw & Co. Inc.D. E. Shaw & Co. Inc. cut its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 46.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 387,733 shares of the company's stock after selling 336,949 shares during tMay 16, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Orbimed Advisors LLCOrbimed Advisors LLC lessened its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 9.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,255,031 shares of the company's sMay 15, 2025 | marketbeat.comAmeriprise Financial Inc. Boosts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Ameriprise Financial Inc. lifted its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 21.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 971,099 sharMay 15, 2025 | marketbeat.comNorthern Trust Corp Acquires 52,908 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Northern Trust Corp grew its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 8.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 655,678 shares of the company's stock after purMay 15, 2025 | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Given "Neutral" Rating at GuggenheimGuggenheim restated a "neutral" rating and issued a $47.00 price objective on shares of SpringWorks Therapeutics in a report on Monday.May 14, 2025 | marketbeat.comIntegral Health Asset Management LLC Purchases Shares of 100,000 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Integral Health Asset Management LLC purchased a new stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 100,000 shares of the company's stock, vMay 14, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by J. Goldman & Co LPJ. Goldman & Co LP cut its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 15.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 53,503 shares of the company's stock afteMay 14, 2025 | marketbeat.comBalyasny Asset Management L.P. Invests $3.10 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Balyasny Asset Management L.P. acquired a new position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 85,761 shares of the compMay 14, 2025 | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Given Neutral Rating at GuggenheimMay 13, 2025 | americanbankingnews.comAlgert Global LLC Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Algert Global LLC bought a new position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 35,340 shares of the company's stock, valued at approximately $1,27May 12, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) is Deep Track Capital LP's 6th Largest PositionDeep Track Capital LP trimmed its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 10.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,460,756 shares of the company's stock after selling 383,144 shares durinMay 9, 2025 | marketbeat.comDuquesne Family Office LLC Acquires 154,628 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Duquesne Family Office LLC boosted its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 21.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 859,694 shares of the company's stock after purchasinMay 9, 2025 | marketbeat.comDimensional Fund Advisors LP Lowers Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Dimensional Fund Advisors LP reduced its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 1.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 717,714 shares of the company's stoMay 9, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Has $14.73 Million Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)The Manufacturers Life Insurance Company increased its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 42.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor ownedMay 6, 2025 | marketbeat.comArrowMark Colorado Holdings LLC Acquires 7,072 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)ArrowMark Colorado Holdings LLC boosted its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 0.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,499,134 shares of the compaMay 5, 2025 | marketbeat.comAlly Bridge Group NY LLC Has $1.98 Million Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Ally Bridge Group NY LLC decreased its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 76.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 54,692 shares of the company's stock after selling 173,008 shaMay 4, 2025 | marketbeat.comBoxer Capital Management LLC Acquires New Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Boxer Capital Management LLC bought a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 3,421,541 shares of the company's stock, valued at approximately $123,620,000. SprMay 4, 2025 | marketbeat.comSpringWorks Therapeutics' (SWTX) "Neutral" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "neutral" rating and set a $47.00 target price (down previously from $74.00) on shares of SpringWorks Therapeutics in a research note on Wednesday.May 2, 2025 | marketbeat.comEvercore ISI Downgrades SpringWorks Therapeutics (NASDAQ:SWTX) to HoldEvercore ISI downgraded SpringWorks Therapeutics from a "strong-buy" rating to a "hold" rating in a research note on Monday.May 2, 2025 | marketbeat.comPromising Growth Stocks To Follow Today - April 29thSpringWorks Therapeutics, Novo Nordisk A/S, Welltower, Apollo Global Management, Repligen, Blackstone, and BlackRock are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to expand their revenues and earnings at anMay 1, 2025 | marketbeat.comBiotech Stocks To Follow Now - April 29thSpringWorks Therapeutics, AbbVie, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any BioMay 1, 2025 | marketbeat.comSpringWorks Therapeutics' (SWTX) "Hold" Rating Reiterated at TD CowenTD Cowen reiterated a "hold" rating and set a $47.00 target price (down from $66.00) on shares of SpringWorks Therapeutics in a research report on Tuesday.May 1, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Stock Position Raised by Soros Fund Management LLCSoros Fund Management LLC lifted its position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 7.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 600,470 shares of the company's stock after acquiring an additioMay 1, 2025 | marketbeat.comHC Wainwright & Co. Downgrades SpringWorks Therapeutics (SWTX)May 1, 2025 | msn.comPromising Value Stocks To Watch Now - April 28thSpringWorks Therapeutics, ProShares UltraPro Short QQQ, iShares Bitcoin Trust, Intel, and Berkshire Hathaway are the five Value stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had tApril 30, 2025 | marketbeat.comTop Mid Cap Stocks Worth Watching - April 28thSpringWorks Therapeutics, ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Hims & Hers Health, and Pony AI are the five Mid Cap stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). ThesApril 30, 2025 | marketbeat.comBest Pharmaceutical Stocks To Watch Now - April 28thSpringWorks Therapeutics, Eli Lilly and Company, AbbVie, Pfizer, Merck & Co., Inc., Thermo Fisher Scientific, and Honeywell International are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (ToApril 30, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Average Recommendation of "Moderate Buy" from BrokeragesSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six ratings firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and four have assignApril 30, 2025 | marketbeat.comMedical Stocks To Add to Your Watchlist - April 28thSpringWorks Therapeutics, Eli Lilly and Company, and UnitedHealth Group are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume oApril 30, 2025 | marketbeat.comPromising Growth Stocks Worth Watching - April 28thSpringWorks Therapeutics, Blackstone, Novo Nordisk A/S, BlackRock, and Apollo Global Management are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dApril 30, 2025 | marketbeat.comTop Biotech Stocks To Watch Today - April 28thSpringWorks Therapeutics, AbbVie, Thermo Fisher Scientific, Vertex Pharmaceuticals, and Danaher are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highestApril 30, 2025 | marketbeat.comSpringWorks Therapeutics' (SWTX) "Equal Weight" Rating Reiterated at BarclaysBarclays reaffirmed an "equal weight" rating and issued a $47.00 target price (down from $63.00) on shares of SpringWorks Therapeutics in a report on Monday.April 30, 2025 | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap Up - What's Next?SpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap Up - What's Next?April 30, 2025 | marketbeat.comSPRINGWORKS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SpringWorks Therapeutics, Inc. - SWTXApril 30, 2025 | businesswire.comSpringWorks Therapeutics (NASDAQ:SWTX) Earns "Neutral" Rating from WedbushWedbush restated a "neutral" rating and set a $47.00 price target (down from $81.00) on shares of SpringWorks Therapeutics in a research report on Monday.April 30, 2025 | marketbeat.comGuggenheim Downgrades SpringWorks Therapeutics (SWTX)April 30, 2025 | msn.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Nebula Research & Development LLCNebula Research & Development LLC lowered its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 21.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 25,020 shares ofApril 30, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Trims Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Price T Rowe Associates Inc. MD reduced its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 6.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,274,786 shares of the company's stock after selling 241,6April 30, 2025 | marketbeat.comBarclays Downgrades SpringWorks Therapeutics (SWTX)April 29, 2025 | msn.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Purchased by Voya Investment Management LLCVoya Investment Management LLC raised its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 9.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 796,684 shares of the company's stock after acquiringApril 29, 2025 | marketbeat.comShareholder Alert: The Ademi Firm Investigates Whether SpringWorks Therapeutics, Inc. Is Obtaining a Fair Price for Its Public ShareholdersApril 29, 2025 | tmcnet.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating SpringWorks Therapeutics, Inc. BuyoutApril 28, 2025 | investing.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of SpringWorks Therapeutics, Inc. - SWTXApril 28, 2025 | prnewswire.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of SpringWorks Therapeutics, Inc.April 28, 2025 | prnewswire.comMerck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 BillionApril 28, 2025 | benzinga.com Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address SWTX Media Mentions By Week SWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SWTX News Sentiment▼1.550.65▲Average Medical News Sentiment SWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SWTX Articles This Week▼117▲SWTX Articles Average Week Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genmab A/S News Today Dr. Reddy's Laboratories News Today Viatris News Today Moderna News Today Ascendis Pharma A/S News Today Qiagen News Today Roivant Sciences News Today Revolution Medicines News Today Elanco Animal Health News Today Blueprint Medicines News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SWTX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
